Tags Clinical study

Tag: clinical study

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.
AR101

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut Therapy

First of 440 patients enrolled in study of AR101.
No time to waste

Epinephrine First, Period

The AAP dispels common misconceptions about when to use the drug with anaphylaxis.

NIH Designates $42 Million to Food Allergy Research Group over 7 Years

CoFAR has done important clinical research since 2005 and will continue with NIH funding.
Viaskin Peanut

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of 2017

The study received higher-than-expected patient demand.
Allergic Living 2017 AAAAI Meeting Coverage

Must Read: Allergic Living’s 2017 AAAAI Meeting Summary

Research highlights from the AAAAI annual meeting held in Atlanta a few weeks ago.

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.

Viaskin Peanut Patch: Lasting Response After Three Years

Pediatric patients responded with a favorable safety profile and no serious adverse effects.
Skin Prick Testing

Food Allergy Immunotherapy Advances Presented at AAAAI Meeting

Here's a quick recap from this morning's AAAAI press release.

Positive Results Announced for Peanut Allergy Vaccine

Another food allergy therapy showing early promise.

Connect with Us

28,284FansLike
84FollowersFollow
3,951FollowersFollow
31SubscribersSubscribe